FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1971558670> ?p ?o ?g. }

• W1971558670 endingPage "161" @default.
• W1971558670 startingPage "155" @default.
• W1971558670 abstract "Despite advances in palliative chemotherapy, patients with advanced non-small cell lung cancer (NSCLC) eventually experience disease progression during or after completion of first-line chemotherapy, which requires salvage therapy. Second- or third-line therapy in selected patients is recommended in the current guidelines. Although fourth-line therapy is often performed in daily practice in some countries, there are few reports about the clinical benefits of fourth-line therapy.A retrospective review was conducted on 383 patients who underwent at least first-line palliative chemotherapy for advanced NSCLC (stage IV or stage IIIB/recurrent disease unsuitable for definitive local therapy). Overall survival (OS) and clinicopathological characteristics were analyzed according to the lines of chemotherapy as well as for all study patients.The median OS for all patients after the initiation of first-line therapy was 11 months. The median OS for patients who received fourth- or further-line therapy (77 patients) was longer than that of patients who received third- or lesser-line therapy (27 versus 9 months, p<0.0001). In multivariate analysis, fourth- or further-line therapy was independently associated with favorable OS (hazard ratio: 0.44, 95% confidence interval: 0.34-0.57, p<0.0001) along with recurrent disease, female, age <70 years, and ECOG performance status (PS) 0 or 1. Median OS after the start of fourth-line therapy was 9 months. Good PS (ECOG PS 0, 1) at the initiation of fourth-line therapy (10 versus 2 months, p<0.0001) and disease control (10 versus 7 months, p=0.011) after first-line therapy were associated with favorable OS in univariate analysis, while poor PS (ECOG PS ≥2) was an independent prognostic factor for poor outcome (p<0.0001).The present study suggests that advanced NSCLC patients with good PS after progression from third-line therapy could be considered as reasonable candidates for fourth-line therapy in clinical practice." @default.
• W1971558670 created "2016-06-24" @default.
• W1971558670 creator A5003756007 @default.
• W1971558670 creator A5006027189 @default.
• W1971558670 creator A5028137817 @default.
• W1971558670 creator A5038041478 @default.
• W1971558670 creator A5043025424 @default.
• W1971558670 creator A5056963227 @default.
• W1971558670 creator A5082747615 @default.
• W1971558670 creator A5085230981 @default.
• W1971558670 creator A5089068543 @default.
• W1971558670 date "2015-02-01" @default.
• W1971558670 modified "2023-09-25" @default.
• W1971558670 title "Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?" @default.
• W1971558670 cites W1981599526 @default.
• W1971558670 cites W1985385147 @default.
• W1971558670 cites W2019607817 @default.
• W1971558670 cites W2020917220 @default.
• W1971558670 cites W2025267040 @default.
• W1971558670 cites W2037139573 @default.
• W1971558670 cites W2038499623 @default.
• W1971558670 cites W2059103130 @default.
• W1971558670 cites W2099725888 @default.
• W1971558670 cites W2112621029 @default.
• W1971558670 cites W2112681490 @default.
• W1971558670 cites W2130629599 @default.
• W1971558670 cites W2130652363 @default.
• W1971558670 cites W2134667653 @default.
• W1971558670 cites W2138297714 @default.
• W1971558670 cites W2143859186 @default.
• W1971558670 cites W2146441359 @default.
• W1971558670 cites W2151090489 @default.
• W1971558670 cites W2151299797 @default.
• W1971558670 cites W2152056906 @default.
• W1971558670 cites W2153580434 @default.
• W1971558670 cites W2165187741 @default.
• W1971558670 cites W2168340462 @default.
• W1971558670 cites W2169961966 @default.
• W1971558670 doi "https://doi.org/10.1016/j.lungcan.2014.11.016" @default.
• W1971558670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25488862" @default.
• W1971558670 hasPublicationYear "2015" @default.
• W1971558670 type Work @default.
• W1971558670 sameAs 1971558670 @default.
• W1971558670 citedByCount "6" @default.
• W1971558670 countsByYear W19715586702015 @default.
• W1971558670 countsByYear W19715586702016 @default.
• W1971558670 countsByYear W19715586702017 @default.
• W1971558670 countsByYear W19715586702018 @default.
• W1971558670 countsByYear W19715586702020 @default.
• W1971558670 crossrefType "journal-article" @default.
• W1971558670 hasAuthorship W1971558670A5003756007 @default.
• W1971558670 hasAuthorship W1971558670A5006027189 @default.
• W1971558670 hasAuthorship W1971558670A5028137817 @default.
• W1971558670 hasAuthorship W1971558670A5038041478 @default.
• W1971558670 hasAuthorship W1971558670A5043025424 @default.
• W1971558670 hasAuthorship W1971558670A5056963227 @default.
• W1971558670 hasAuthorship W1971558670A5082747615 @default.
• W1971558670 hasAuthorship W1971558670A5085230981 @default.
• W1971558670 hasAuthorship W1971558670A5089068543 @default.
• W1971558670 hasConcept C126322002 @default.
• W1971558670 hasConcept C141071460 @default.
• W1971558670 hasConcept C143998085 @default.
• W1971558670 hasConcept C146357865 @default.
• W1971558670 hasConcept C151730666 @default.
• W1971558670 hasConcept C167135981 @default.
• W1971558670 hasConcept C207103383 @default.
• W1971558670 hasConcept C2776256026 @default.
• W1971558670 hasConcept C2776694085 @default.
• W1971558670 hasConcept C2776907518 @default.
• W1971558670 hasConcept C2780775027 @default.
• W1971558670 hasConcept C44249647 @default.
• W1971558670 hasConcept C71924100 @default.
• W1971558670 hasConcept C86803240 @default.
• W1971558670 hasConceptScore W1971558670C126322002 @default.
• W1971558670 hasConceptScore W1971558670C141071460 @default.
• W1971558670 hasConceptScore W1971558670C143998085 @default.
• W1971558670 hasConceptScore W1971558670C146357865 @default.
• W1971558670 hasConceptScore W1971558670C151730666 @default.
• W1971558670 hasConceptScore W1971558670C167135981 @default.
• W1971558670 hasConceptScore W1971558670C207103383 @default.
• W1971558670 hasConceptScore W1971558670C2776256026 @default.
• W1971558670 hasConceptScore W1971558670C2776694085 @default.
• W1971558670 hasConceptScore W1971558670C2776907518 @default.
• W1971558670 hasConceptScore W1971558670C2780775027 @default.
• W1971558670 hasConceptScore W1971558670C44249647 @default.
• W1971558670 hasConceptScore W1971558670C71924100 @default.
• W1971558670 hasConceptScore W1971558670C86803240 @default.
• W1971558670 hasIssue "2" @default.
• W1971558670 hasLocation W19715586701 @default.
• W1971558670 hasLocation W19715586702 @default.
• W1971558670 hasOpenAccess W1971558670 @default.
• W1971558670 hasPrimaryLocation W19715586701 @default.
• W1971558670 hasRelatedWork W1900595920 @default.
• W1971558670 hasRelatedWork W1987468340 @default.
• W1971558670 hasRelatedWork W2055244776 @default.
• W1971558670 hasRelatedWork W2114624491 @default.
• W1971558670 hasRelatedWork W2166867133 @default.
• W1971558670 hasRelatedWork W2194631636 @default.

• next